Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25
In Brief: Search Committee Finds Prospects Uncertain About Election, Unwilling To Take Pay Cut
Intarferon Results Promising, ACS Says, And commits Another $3.4 Million
Randomization With Options Stimulates Sedmental Accrual
It’s Official; Most of NCI NTP contingent Will Move To N.C.
Guidelines Adopted For Pathology Review
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research
- Did Vinay Prasad need to mention the Nazis to make a point on the U.S. pandemic response?